A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Type
Private
HQ
Toronto, CA
Founded
2012
Size (employees)
7 (est)
Encycle Therapeutics was founded in 2012 and is headquartered in Toronto, CA
Report incorrect company information

Key People/Management at Encycle Therapeutics

JEFFREY COULL PhD

JEFFREY COULL PhD

President and CEO
Andrei Yudin PhD

Andrei Yudin PhD

Scientific Founder, SAB
Raphael Hofstein PhD

Raphael Hofstein PhD

Chairman

Encycle Therapeutics Office Locations

Encycle Therapeutics has an office in Toronto
Toronto, CA (HQ)
314 101 College St
Show all (1)
Report incorrect company information

Encycle Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$4.6 m

Latest funding size

$2.13 m

Time since last funding

3 years ago

Investors

Encycle Therapeutics's latest funding round in September 2015 was reported to be $2.1 m. In total, Encycle Therapeutics has raised $4.6 m
Show all financial metrics
Report incorrect company information